City Holding Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

City Holding Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	509
2021 Q3	$0	Hold	1	–	–	﹤0.01%	501
2021 Q2	$0	Buy	+1	New	+$173	﹤0.01%	517

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

City Holding Co's JAZZ Position: Q4 2021 in Review

City Holding Co sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 1 share.

City Holding Co first reported a position in JAZZ in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q3 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

City Holding Co reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
City Holding Co sold 1 Jazz Pharmaceuticals share in Q4 2021.
City Holding Co first reported a position in Jazz Pharmaceuticals in Q2 2021 and held it in 2 quarters.
City Holding Co's Jazz Pharmaceuticals position peaked at $0 in Q3 2021.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on City Holding Co's 13F filing for Q4 2021, filed 11 Mar 2022.